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Systemic lupus erythematosus (SLE) is a multisystem,
autoimmune disorder characterised by the formation of
antibodies to cellular components.
Worldwide, 15 - 17% of SLE patients present before 16 years
of age, with a peak incidence at 10 - 14 years. It is rare in
children below 4 years old, and there is a female predominance
in adolescence and adulthood. The true incidence of childhood
SLE is difficult to determine. Old data suggest that it was a
very rare disease, but this was largely because mild and early
cases went unrecognised until end-organ damage made the
disease unmistakable. Even today, many children present late
as the early signs are not recognised and linked with this
disease.1
Children may present with skin rashes, arthritis, and
nonspecific constitutional symptoms that may precede the
finding of organ-specific disease. The incidence of renal
pathology is high both on presentation and later in the disease
process. It has also been suggested that race plays a role in SLE,
predominantly in the outcome. In South Africa SLE was
thought to be rare in black patients. In total there have been
only 4 publications dealing with childhood SLE in South Africa
between 1981 and 1994. As there is a paucity of data in South
Africa on childhood SLE, this study aimed to document the
clinical features and demographics of children with SLE at
specific referral centres in Gauteng.
Patients and methods
A retrospective review and analysis was done of all the
children attending the renal and arthritis clinics at
Johannesburg Hospital and the renal clinic at Chris Hani
Baragwanath Hospital from January 1974 to March 2000. These
are academic teaching hospitals and referral centres of the
University of the Witwatersrand. These referrals were from
primary care paediatricians, secondary-level hospitals, and the
hospitals’ general wards, which accept patients from Gauteng
and North-West provinces. A single reviewer (GF) examined all
the records. Patients who fulfilled 4 or more of the American
College of Rheumatology (ACR) criteria for SLE, either on
presentation or sequentially, were included.2 Gender, race, age
and clinical features on first presentation were recorded. The
patient’s age was recorded at the time of initial presentation at
the referring centre. Clinical features documented in referral
letters or obtained at the time of the first visit were also
recorded. The results of renal biopsies done within the first 3
months were included as part of the initial presentation.
Results
Thirty-six patients fulfilled the ACR criteria. There were 10
boys and 26 girls, reflecting a ratio of 1:2.6 overall, with a ratio
of 1:1.2 under and 1:4 over 10 years. The mean age on
presentation was 10.9 years (boys 10.2 years, girls 11.3 years),
with a range of 4.8 - 16.1 years. There were 15 white, 14 black, 2
Indian and 5 coloured patients. All the black patients presented
after 1986.
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patients all presented after 1986. Rashes were found to be the
commonest clinical feature present at the time of diagnosis,
followed by polyarthritis and renal pathology. Constitutional
symptoms were common, as were generalised lymphadeno-
pathy and hepatosplenomegaly, while neurological, pulmo-
nary and cardiac signs and symptoms were less common.
Renal disease was present in 58% of patients on presentation.  
Conclusion. There is a diverse array of presenting features in
childhood SLE. There has been increased recognition of the
disease in young black South Africans since 1986.
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Clinical features
Cutaneous signs were the commonest feature on initial
presentation (Table I). Twenty-eight patients had 1 or more of
the typical lupus rashes (77%), with 47.2 % having a malar
rash, and 25% having mucocutaneous ulceration.
Constitutional features were common, but nonspecific.
Hepatosplenomegaly, generalised lymphadenopathy, arthritis
and arthralgia were also common as were central nervous
system (CNS) complaints, including persistent headaches,
always a difficult symptom in childhood.
Three patients presented with pneumonia and 3 had
Raynaud’s phenomenon. There were 3 patients with cardiac
disease (cardiomyopathy, cardiac failure, myocarditis), 2 with
disseminated sepsis and 4 with abdominal pain, 1 of which
cases proved to be pancreatitis. One patient (a boy) was treated
for 2 years for idiopathic thrombocytopenic purpura (ITP). 
The duration from onset of symptoms to diagnosis was not
always known. This information was available for 20 of the 36
patients (55.5%). The average time to diagnosis for these 20
patients was 16 months from onset of symptoms. In those
children without arthritis and cutaneous manifestations, it took
longer for the diagnosis to be established, and it was made
most quickly in those presenting with renal disease, indicating
that a higher index of suspicion existed in these patients. The
longest recorded duration of 5 years was in a girl who had a
hemiparesis and primarily neurological symptoms since the
age of 7. She had been followed up for these symptoms, and
the diagnosis was made at 12 years old when she developed
cutaneous features (discoid lesions and mucocutaneous
ulceration).  
Renal disease
Twenty-one patients had early renal biopsies, 16 of whom
presented with symptoms of disease. On biopsy 3 of these
patients were found to be of mixed World Health Organization
(WHO) classification, and were then classified under the
dominant class. Sixteen of the patients were either class III or
IV at presentation (76% of the total biopsied). Presentation of
the children with renal disease was varied; nephrotic syndrome
was the most common. One child was in renal failure at the
time of diagnosis. 
Discussion
This is the first series on South African children with SLE. A
review of the literature revealed 4 reports of children with SLE
in South Africa, a report of 3 cases in 1981,3 and a report in
19864 on 6 cases of SLE with lupus nephritis.  The first case
report of a black child with this disease was published in 1991,5
although there were undoubtedly patients recognised before
this time. A subsequent report in 1994 dealt with outcomes.6
The racial characteristics are interesting in a country like
South Africa. The group consisted of 42% white patients, which
is not representative of the demographics of the country. Some
of this may be explained on a historical basis where under the
apartheid system black patients had less access to tertiary-level
health care. SLE was thought to be extremely rare in this group
and a large number of patients may have gone undiagnosed, or
may have died with the disease unrecognised. The prevalence
of SLE in adult black South Africans has been estimated to be
12.2/100 000,7 but no figures exist for children in South Africa.
A ‘best guess’ estimate of the prevalence in our area is 1/100
000, extrapolated from the data provided by  Ransome and
Thomson.4,8 The number of black patients presenting after 1986
shows that SLE is increasingly recognised in this group of
patients in South Africa.
This series showed the age of presentation, with a peak at
10.9 years and no patient presenting under the age of 4.
However, the mean age is lower than in other reported series,9
which have suggested a peak in the adolescent years.  Before
about 1995, in the hospitals from which this study population
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Table I. Clinical presenting features  
Features Number Percentage
Cutaneous features (malar rash 17, 
discoid lesions 4, vasculitis 8, alopecia 5, 
mucocutaneous ulceration 9, 
photosensitivity 4, urticaria 1) 28 77
Constitutional features
(fever, myalgia, fatigue, weakness, 
weight loss) 20 55.5
Renal disease (nephrotic syndrome 8, 
hypertension 3, acute glomerulo-
nephritis 3, haematuria 1,




Serositis (pericardial effusion 3,
pleural effusion 4) 7 19.4
CNS symptoms (seizures 1, 
encephalopathy 1, depression 2, 
hemiparesis 1, chorea 1, 
headache 3, psychosis 1) 7 19
Arthralgia 4 11.1
Abdominal pain 4 11.1
Pneumonia 3 8.3
Raynaud’s phenomenon 3 8.3
Cardiac disease 3 8.3
Disseminated sepsis 2 5.5
Pancreatitis 1 2.7
ITP 1 2.7
ITP = idiopathic thrombocytopenic purpura.
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was drawn, all children over the age of 12 were considered
better managed in the adult wards and clinics because of
severe lack of bed space. To some degree this may explain the
relative paucity of teenagers, especially boys, in this group. The
male/female ratio in childhood has varied in reported studies
from 1:5.5 (Boston) and 1:2.8 (Israel) to the same rate as in
adults (1:20, UK).10 In this series our ratio was 1:2.6 (72%
female); in children under 10 years the male/female ratio was
almost equal (1:1.2) while in those 10 years and older it was
1:4.
Among the most prominent presenting features of childhood
SLE are arthralgia, arthritis, malar rash and fever, which were
well demonstrated here. The classic malar rash present in 47%
of patients in this study has been described as occurring in
about one-third of patients. Possibly this was so common in
our group as it is an obvious lupus symptom at the time of
referral. More commonly, patients have been reported to have
maculopapular rashes in sun-exposed areas (SLE being
typically very photosensitive), mucocutaneous ulceration and
vasculitis of the fingers that may be associated with Raynaud’s
phenomenon, a common phenomenon in adolescent girls.
Fourteen of these children had arthritis at presentation. The
arthritis of childhood SLE, as of adults, is generally non-
destructive and non-deforming. The commonly affected joints
are the knees, wrists, and proximal interphalangeal joints. It
may be migratory.  In this study this incidence was high at
38.8%, with a further 11% reporting arthralgia. If combined
with other musculoskeletal symptoms such as myalgia and
weakness, the percentage rises even higher.
Nephritis, often with a nephrotic component, is not unusual
as the presenting feature of SLE, as the kidney is the most
commonly affected organ in children. Fifty-eight per cent of
our patients had evidence of lupus nephritis on biopsy at the
time of presentation. Prevalence rates in childhood range from
50% to 80% of all patients.11 Outcomes are dependent on the
severity of the histopathological lesions. In this study, 76% of
the total number of children biopsied (21) were WHO class III
or IV, indicating a poorer prognosis. In several instances
children have presented with ‘full house’ nephropathy before
the onset or recognition of SLE.12
There were several unusual presentations such as cardiac
diseases usually associated with longer time of disease,
pancreatitis, and disseminated sepsis as the first presentation.
The children who presented with these diseases had an
average time of 8 months to diagnosis from first presentation,
but the actual duration of symptoms is somewhat uncertain.
Cardiac disease may present as myocarditis, pericarditis,
pericardial effusion, cardiac tamponade, and endocarditis
(Libman-Sacks type). It is interesting that 3 patients (8.3%) had
cardiac disease as their presenting feature in this study. While
this has been described previously, it suggests that lupus not
only presents late in our population, but may also have an
insidious course until end-organ disease is present.
Documentation of pancreatitis in paediatric SLE is
uncommon.  Severe SLE may be complicated by both acute and
chronic pancreatitis, and pancreatic pseudocyst formation has
been reported, although this is an extremely rare situation.13
Disseminated sepsis is a manifestation of the immune
suppression in SLE. The most common sites for infection are
the skin, respiratory tract, urinary tract and CNS although the
osteoarticular system is also frequently involved. As these
systems are involved on the basis of primary immune
suppression, it is not surprising that some of the children in
this series initially presented with symptoms of sepsis.14
In our series 19% of patients had 1 or more neurological
symptoms on presentation. CNS involvement includes frank
psychosis, strokes, seizures, chorea and coma. The patients in
this series showed the presence of all of these, which frequently
occur without warning during the progression of the disease,
but may be presenting features, as was the case here.  Children
have presented for neurological or psychiatric assessment
before the diagnosis of SLE, and in 1 series of 10 patients, all
had symptoms within 4 years of diagnosis including
neurological and psychiatric symptoms.15 It is interesting that
the child in this series with the longest history before her
diagnosis was made, was being treated for a variety of
neurological complaints. Most commonly reported is the
occurrence of seizures, followed by headaches, but our series
showed headaches as the commonest complaint on
presentation, followed by depression. Psychosis and
depression are both known to be presenting features. The
pathogenesis of neuropsychiatric SLE is probably
multifactorial. It may result from cerebritis, vasculitis, or
hypertension; it may also be the result of therapy, or secondary
to events such as cerebrovascular accidents. In adolescence,
interpreting these signs may be made more difficult by the
psychological problems associated with coping with a chronic
illness.1
Pulmonary features occuring in children with lupus include
pleuritis, acute pneumonitis, chronic interstitial lung disease,
pulmonary fibrosis, alveolar haemorrhage, respiratory and
diaphragm myopathy, and pulmonary hypertension. Studies
have reported incidences from 5% to 67%. Children may also
not have symptoms of pulmonary disease but show significant
impairment on lung function testing.16 In this study there was
only documentation relating to acute pneumonitis on
presentation. No references were found to pulmonary function
testing at diagnosis. We are therefore unable to judge the real
incidence of early pulmonary disease in our group of patients.  
One patient presented with ITP, which was treated for some
time before the diagnosis was made. Such a patient may have
had no other signs at the time of initial presentation, but
careful periodic re-evaluation will reveal the progression to
SLE. 
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In summary, this study documents the diverse ways in
which children with SLE in South Africa have presented, and
the incidence of renal disease in our population. The findings
suggest that patients in our population are being missed early
on, and therefore present late, and that childhood SLE is an
insidious disease initially. Table II summarises the likely
clinical features of SLE, and may help the generalist to
recognise these children. It is promising for the future that an
increasing number of black children are being recognised and
referred to tertiary care institutions for management.   
This study was approved unconditionally by the Ethics
Committee of the University of the Witwatersrand, protocol
number M00/03/36.
This work was delivered as an oral presentation at the 17th
Congress of the South African Rheumatism and Arthritis
Association, held in Pretoria, South Africa, 31 March - 2 April 2001.
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Table II. Warning signs of childhood SLE  
A. Consider if 2 or more of the following are present, especially








7. Ongoing constitutional symptoms
8. Lymphadenopathy/hepatosplenomegaly
B. SLE is highly likely if there is multiorgan involvement of 2 or
more of the following, and any feature mentioned under A:




GIT = gastrointestinal tract.
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